Cargando…

Does the key to treat Rheumatoid nodules lie with oncology? - Is Cisplatin an option?

Detalles Bibliográficos
Autores principales:	Omar, Eisha K, Adimulam, Suresh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582422/ http://dx.doi.org/10.1186/1471-2474-14-S1-A5

Ejemplares similares

Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000)

Truth and lies about the social rehabilitation of drug addiction
por: Georgakas, Panagiotis
Publicado: (2010)

Radiofrequency obliteration to treat the great saphenous vein insufficiency, an option in geriatrics patients
por: Bonfiglio, B, et al.
Publicado: (2010)

The necessity of a structured framework for considering pathological lying in the forensic context
por: Paraskevoulakou, Alexia, et al.
Publicado: (2010)

The technical aspects of adapting add-on digital stereotactic equipment for use with patient lying horizontally
por: Rubin, G, et al.
Publicado: (2000)

Quality in Assisted Living: Does It Lie in the Eyes of the Beholder?
por: White, Diana, et al.
Publicado: (2020)

Thyroid nodules in children - rules of management
por: Bobeff, Irena
Publicado: (2015)

Oncology
por: Smith, I
Publicado: (2000)

Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response
por: Marotte, H, et al.
Publicado: (2003)

Positivity of HLA-DRB1 rheumatoid epitope does not predict the course of juvenile idiopathic arthritis in Czech children
por: Cinek, O, et al.
Publicado: (2001)

Infiltrate analysis of rheumatoid synovial tissue before and after high does chemotherapy and autologous stem cell transplantation
por: Verburg, RJ, et al.
Publicado: (2001)

Epstein–Barr virus load follow up in rheumatoid arthritis patients treated with TNF-α inhibitors
por: Balandraud, N, et al.
Publicado: (2004)

Flexible screening clinics: future options
por: Dyson, SA, et al.
Publicado: (2000)

To Lie or Not to Lie: The Views of People With Dementia and Their Carers
por: Casey, Dympna, et al.
Publicado: (2020)

Lung Metastatic Nodules as First Presentation of Synovial Cardiac Sarcoma
por: Ampatzidou, F, et al.
Publicado: (2015)

Cisplatin in breast cancer treatment in BRCA1 carriers
por: Gronwald, Jacek, et al.
Publicado: (2012)

Apoptosis in Rheumatoid Synoviocytes
por: Nishioka, Kusuki
Publicado: (2000)

Genetics of Rheumatoid Arthritis
por: Nepom, Gerald T
Publicado: (2000)

Chemokines in Rheumatoid Arthritis
por: Koch, Alisa
Publicado: (2000)

CNP attenuates renal toxicity induced by cisplatin in murine kidney
por: Kimura, Toru, et al.
Publicado: (2015)

Polypharmacy in schizophrenia - therapeutic option or a sign of despair?
por: Konstantinidis, Anastasios
Publicado: (2010)

TAo TAVI + OPCABG: a new hybrid option
por: Brazier, Andrew, et al.
Publicado: (2015)

Autoreactivity patterns in rheumatoid arthritis
por: Behrens, S, et al.
Publicado: (2001)

Mast Cells and the Rheumatoid Lesion
por: Woolley, David E, et al.
Publicado: (2000)

Urological involvements in pelvic oncologic surgery
por: Acconcia, A
Publicado: (2010)

Actual trends in palliative oncologic surgery
por: Patrizi, G, et al.
Publicado: (2011)

PHC: the future of oncology drug development
por: Yao, Yihong
Publicado: (2012)

P03-013-B - Inaugural palate nodule of a systemic sarcoidosis
por: Mael-Ainin, M, et al.
Publicado: (2013)

Role of Standardized Perfusion Value (SPV) in the characterization of Solitary Pulmonary Nodules (SPN)
por: Reginelli, A, et al.
Publicado: (2011)

Why choose the treatment with cisplatin for BRCA1 breast cancers patients?
por: Byrski, T, et al.
Publicado: (2012)

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
por: Byrski, T, et al.
Publicado: (2011)

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment
por: Byrski, T, et al.
Publicado: (2012)

Genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

DNA therapeutics: a feasible option for treatment of inflammatory diseases?
por: Wagner, E
Publicado: (2001)

Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody (HORUS TRIAL)
por: Elshahaly, Mohsen, et al.
Publicado: (2013)

Anti-BIP antibodies in rheumatoid arthritis
por: Panayi, GS, et al.
Publicado: (2003)

Fibrinogen-specific T cells in rheumatoid arthritis
por: Vossenaar, E, et al.
Publicado: (2003)

Dendritic cell subsets in rheumatoid arthritis
por: Summers, K, et al.
Publicado: (2001)

Histopathology of Bone Erosions in Rheumatoid Arthritis
por: Gravallese, Ellen, et al.
Publicado: (2000)

Synovial Histopathology in Early Rheumatoid Arthritis
por: Hirohata, Shunsei, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_5c6hmtlc5qs7gra00mdg7l5cv4